Concepedia

A. Krishnan

AK

Statistics

Publications

21

Citations

1.2K

H-Index

16

Active since

2000

Affiliations

City of Hope(Current)

City Of Hope National Medical Center

Dana-Farber Cancer Institute

Moffitt Cancer Center

Hackensack University Medical Center

A. Krishnan is an author at City of Hope specializing in medicine, hematologic malignancy therapy, and multiple myeloma.

ORCID

Publications per year

2000–2023

21

Publications

21

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

André Goy, Steven H. Bernstein, Brad S. Kahl et al. · Annals of Oncology · 2008 · 340 citations · Full text

, , +13

A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome

Henry C. Fung, Anthony S. Stein, Marilyn L. Slovak et al. · Biology of Blood and Marrow Transplantation · 2003 · 118 citations

, , +15

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time

Shaji Kumar, Angela Dispenzieri, Raphael Fraser et al. · Leukemia · 2017 · 89 citations

, , +16

Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: Results of a prospective double-blind randomized trial

Nelson J. Chao, DS Snyder, Maneesh Jain et al. · Biology of Blood and Marrow Transplantation · 2000 · 82 citations

, , +13

Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study

Shaji Kumar, Ian W. Flinn, Stephen J. Noga et al. · Leukemia · 2010 · 81 citations

, , +16

1–5 of 21